Basic information |
Metabolite name | Phosphocreatine |
HMDB0001511 | |
C02305 | |
587 | |
Synonyms | Phosphoctreatine |
No. of studies | 13 |
Relationship between Phosphocreatine and depression (count: 13) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M116 | Type3 | ketamine group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
Study M116 | Type3 | ketamine group vs. control group | Cerebrospinal fluid | Sprague-Dawley rat | Up |
Study M134 | Type1 | CRS group vs. control group | Urine | Sprague-Dawley rat | Down |
Study M134 | Type2 | CRS + BH group vs. CRS group | Urine | Sprague-Dawley rat | Up |
Study M237 | Type3 | SAMe-treated post-treatment vs. pre-treatment | Brain | Human | Up |
Study M260 | Type4 | T3 augmentation treatment responder group vs. non-responder group | Brain | Human | Down |
Study M286 | Type2 | creatine-treated depression group post-treatment vs. pre-treatment | Brain | Human | Up |
Study M317 | Type2 | creatine-treated depression group post-treatment vs. pre-treatment group | Frontal lobe | Human | Up |
Study M348 | Type1 | depression group vs. control group | Gray matter | Human | Up |
Study M348 | Type1 | depression group vs. control group | White matter | Human | Down |
Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
Study M461 | Type1 | LD group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
Study M595 | Type1 | CRS group vs. control group | Nucleus accumbens | C57BL/6J mouse | Down |
Study M595 | Type2 | CRS + acetyl-L-carnitine group vs. CRS group | Nucleus accumbens | C57BL/6J mouse | Up |
Study M799 | Type1 | MDD group vs. control group | Middle temporal visual area | Human | Down |
Study M809 | Type1 | CUMS group vs. control group | Serum | Kunming mouse | Up |
Study M809 | Type2 | CUMS + Milletia speciosa Champ group vs. CUMS group | Serum | Kunming mouse | Down |
Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |